Premaitha Health is a molecular diagnostics company developing, manufacturing and selling IVD products that will have a major beneficial impact on human health
Premaitha Health plc, the international molecular diagnostics group which commercialises genetic products and services that positively impact human health, is pleased to confirm the renaming of the Group as Yourgene Health plc, follow us @Yourgene_Health for future updates
Premaitha Health plc, the international molecular diagnostics group which commercialises genetic products and services that positively impact human health, is pleased to confirm the renaming of the Group as Yourgene Health plc, follow us @Yourgene_Health for future updates
Take a look at how MSP customer @PremaithaHealth is driving advancements in the #medtech sector with its pioneering prenatal screening test: https://t.co/3BraKDTtuq
If you're at the @MedTechCon and would like to know more, let us know here: https://t.co/UPbHFXwhPZ #MedTechCon
Premaitha are currently recruiting for a Manufacturing and Logistics Manager. Please send a CV and covering letter explaining why you would be suitable for the role to [email protected]
https://t.co/J6zhmzR63k https://t.co/J6zhmzR63k
Premaitha are currently recruiting for a Manufacturing and Logistics Manager. Please send a CV and covering letter explaining why you would be suitable for the role to [email protected]
https://t.co/J6zhmzR63k
.@PremaithaHealth are honoured to work so closely with the NHS and would like to wish #NHS70 a Happy 70th Birthday! Thank you to all of the amazing staff for all your hard work.
.@PremaithaHealth are delighted to have won the ‘Outstanding NIPS Solution Provider of the Year’ award at the China & America Precision Medicine Forum in Shanghai #NIPT
Today is #DNADay18. .@theIONAtest analyses cell-free placental #DNA from a maternal blood sample to determine the chance of a fetus being affected with trisomy 21, 18 or 13, test results are available in as little as 3 days
.@PremaithaHealth will be closed over the Easter period including Friday 30th March and Monday 2nd April 2018. All enquiries will be dealt with as soon as possible.